STAT Plus: Eye docs urge Medicare to lower insurance hurdles amid shortage of repackaged Avastin
The largest supplier of repackaged Avastin began a recall this month after the FDA inspected its facilities and found sterility issues
Read The StoryPharma
Taking stock of the drug industry from the lab to the medicine chest. We follow clinical trials, dig deep into FDA drug approvals, track Big Pharma lobbyists and break down financials. From supply chains to Medicare negotiations, count on STAT.
Sign up for our free Pharmalot newsletter and subscribe to STAT+ for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.
STAT Plus: Vampiric cancer cells, a brain atlas, & alleged misconduct at Cassava
STAT Plus: Cell and gene therapies could be a safer bet than other drugs
STAT Plus: CRO claims there was no misconduct in Lyme vaccine trial it ran for Pfizer
The history of OxyContin, told through unsealed Purdue documents
All Coverage
advertisement
